The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.
“Over the last five years Fullerex has engaged with dozens of nanomaterial producers. Very few have demonstrated the same degree of rigour throughout the entire production process as Versarien. The morphology and consistency of Versarien’s Nanene and Hexotene products make them technically and commercially viable in several important application areas that have large, immediate and well defined demand from industry. Fullerex is well positioned to accelerate the incorporation of Nanene and Hexotene into these markets........
Interview with above from Graphene,Manchester.
Worth 30 mins of you time.
https://directory.libsyn.com/episode/index/id/8461307
Worth a watch.
https://www.youtube.com/watch?v=JUPQ1uZKQRc&feature=youtu.be
https://www.standard.co.uk/futurelondon/cleanair/shenzhen-leads-the-way-in-electric-buses-and-taxis-a4016176.html
This link not the same but may work?
Thnx BurtonS, some great feedback and appreciated. Sounds like company is on a very sound footing and any future cash call has been accepted and carefully planned.
Certainly anxious of a next RNS which may be indicative of well anchored progress, hopefully.
One thing I know. Any experts on here would not likely be on here. More likely on a beach somewhere.
If anyone see's themselves as a good financial advisor, suggest get yourselves an office and a phone.
I know I have had enough of gold, silver and Italy and other companies and politics on here.
Filter button poised.
Rchad993 More a lack of research by yourself. NR stated recently that none of its sample tests or trials with anyone had failed what it was tested for, therefore confidence will be high in consistency, quality, reliability, repeatability and will not take years as it is happening now. Lift head from the sand mate.